Department of Immunology and Allergy, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical city-WR, Jeddah, Saudi Arabia.
International Journal of Science and Research Archive, 2025, 17(02), 1208-1226
Article DOI: 10.30574/ijsra.2025.17.2.3108
Received on 19 October 2025; revised on 21 November 2025; accepted on 28 November 2025
Reticular dysgenesis is the most severe form of severe combined immunodeficiency, that is associated with agranulocytosis as part of the disease, which is unresponsive to GCSF. The disease is inherited as autosomal recessive disorder due to genetic mutation of adenylate kinase 2. It is the first described inherited mitochondriopathy disorder that cause primary immunodeficiency and bilateral sensorineural deafness. The disease is lethal in infancy, and those patients are at high risk for infections as the leading cause of death. The only curative therapy of choice is Hematopoietic Stem Cell Transplantation, if HLA match donor is readily available.
Reticular Dysgenesis; Adenylate Kinase; Adenosine Triphosphate; Adenosine Diphosphate; Oxidative Phosphorylation; Severe Combined Immuno-Deficiency; Granulocyte Colony-Stimulating Factor; Cytomegalovirus, Pneumocystis Jiroveci Pneumonia; Hematopoietic Stem Cell Transplantation; Human Leukocyte Antigen
Get Your e Certificate of Publication using below link
Preview Article PDF
Daifulah M. AL-Zahrani. Reticular dysgensis; Overview on the pathophysiology, clinical manifestations, investigations, laboratory findings, treatments and future perspectives. International Journal of Science and Research Archive, 2025, 17(02), 1208-1226. Article DOI: https://doi.org/10.30574/ijsra.2025.17.2.3108.
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0







